| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.51 | 0.001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |